It has been proposed that GPC1-positive exosomes are highly expressed in the sera of pancreatic cancer patients and the exosomal protein GPC1 (AUC= 1.0) yields significantly better performance than CA19–9 (AUC = 0.739) in differentiating pancreatic cancer patients from healthy controls (28). Here, GPC1 is linked to pancreatic neoplasm.